alliance growers · compound annual growth rate of 37.38% from 2016 to 2020. unlike thc, ... across...
TRANSCRIPT
Investor Presentation June 2018CSE: ACG
© 2018 Chilco Design Studio Inc.
ALLIANCEGROWERS
Certain information regarding the company contained herein may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements may include estimates, plans, expectations,
opinions, forecasts, projections, guidance or other statements that are not statements of fact.
Although the company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. The company cautions that actual performance will be affected by a number of factors, many of which are beyond the company’s control, and that
future events and results may vary substantially from what the company currently foresees.
The company’s forward-looking statements are expressly qualified in their entirety by this cautionary statement.
Forward-Looking Statements Disclaimer
Medical Marijuana Industry Potential
The global legal marijuana market is expected to grow at a compound annual growth rate of 37.38% from 2016 to 2020. Unlike THC, CBD is non-psychoactive so it can be more widely marketed for medical
use in children.
Cannabidiol (CBD)
Cannabidiol (CBD) is an organic chemical compound that can be extracted as an oil from cannabis plants. These molecules act on cannabinoid receptors in cells that alter neurotransmitter release in the brain.
CBD oil has been shown to be effective in treating:
y epilepsy y anxiety / depression y schizophrenia y type 2 diabetes y heart disease y certain forms of cancer
More research continues to be done to expand the potential of CBD and its applications.
The Hemp Business Journal reports that the CBD market is growing at a rate of 30% per annum, and forecasts that sales of CBD Oils from marijuana-based sources are expected to reach $1.6 billion or 79% of the Total CBD Market of $2.1 billion by 2020.
WA
BC
YT
NT NU
AK
ABSK MB
ON QC
NL
NB
VTVT
CTCTNH
PENS
RINJDEMD
MA
OR
Medical
CBD Oil Only
Decriminalized
Recreational
CA
NV
AZNM
CO
MT
NE
MO
MS
OK
IA
WI
NCTN
AL GASC
VAKY
ND MN
MI
IL OHPA
NY
ME
FL
Canada & USAIn 2012 the state of Washington legalized the sale and use of recreational marijuana. There are now more than 300 retail outlets, generating hundreds of millions of dollars in sales. Across the US, recreational sales are estimated to grow from $2.6 billion in 2016 to $11.2 billion by 2020.
In the USA, the CBD market is growing at a rate of 30 percent per year, forecast to reach $2.1 billion by 2020. Medical marijuana sales are projected to grow from $4.7 billion in 2016 to $13.3 billion in 2020.
Alliance Growers will initially target the U.S. market where 28 states plus the District of Columbia have legalized medical marijuana and 15 other states that currently allow for the sale of CBD products.
In August 2016, Canada enacted the Access to Cannabis for Medical Purposes Regulations (ACMPR) which allows commercial production by licensed producers. Federal legalization of retail distribution and sale of cannabis is planned for July 2018.
The Province of Quebec is anxious to develop a base of skilled licensed producers to provide a self-sustaining supply for province-based demand of both recreational and medical cannabis.
As Quebec represents approximately 20% of Canada’s population it is currently under-represented in regards to ACMPR licenced companies.
Alliance Growers believes it is advantageous to capitalize on the mandate to increase the number of ACMPR licensed companies in Quebec. We are pleased to have now entered the grow space in Quebec as we negotiate additional license applicants in this province.
Worldwide y Israel has permitted the medical use of cannabis since the early 1990’s.
y Portugal decriminalized the possession of all drugs for personal use in 2001.
y Czech Republic passed a medical cannabis bill in 2013.
y Italy legalized cannabis as a prescribed medication in 2013.
y Uruguay voted to create a national legal marijuana market in 2013.
y Mexico passed a bill to legalize the use of marijuana and cannabis for medical and scientific needs in April 2017.
y Germany passed an act to legalize the use of marijuana for medicinal purposes which came in to effect March 2017.
Partially or Essentially Legal
Decriminalized
Unenforced
Determend by State or Region
Illegal or Unknown
ALLIANCE GROWERS
CBD Oil Supply & Distribution
Research &Technology
LicencedCannabis Growers
CannabisBiotech Complex
CannabisBiotech Complex
The Four Pillar Strategy
Alliance Growers has organized into four divisions in order to focus our potential for success in the medical marijuana market.
Alliance Growers Seed to Sale Vertical Integration
GeneBank
Tissue CulturePlantlets Greenhouses Extraction
Lab
Biotech Complex
Biocannatech OthersCanwe
Growers
GenomicLab B.R.I.M.
Reseach & Development
Spyder Others
Retailers
The Cannabis Biotech Complex
With its partner WFS Pharmagreen, Alliance Growers Corp is establishing the first in a series of Cannabis Biotech Complexes with additional
industial scale greenhouses built in Mission, BC.
Property Development
Pharmagreen has already purchased the land upon which the proposed Cannabis Biotech Complex will be built in Mission, BC
38482 BELL ROADBCBC PART 3 BUILDING
3.2.2.75. GROUP F2 MEDIUM HAZARD INDUSTRIAL MAXIMUM 4 STOREYS / ONE STOREY ACTUAL
BUILDING AREA MAXIMUM @ 1 STOREY = 9,600m2
COMBUSTIBLE OR NONCOMBUSTIBLE SPRINKLERED
1
A
7
F
NORRISH CREEK FOREST SERVICE ROAD
BELL ROAD
10.29 ha25.43 acres
38482 BELL ROAD
89° 42' 16"S W
977.68' PROPERTY LINESEGMENT A
89° 02' 03"S W
462.47' PROPERTY LINESEGMENT B
0° 43' 13"N
W
412.35 ' PROPERTY LINE
61° 55' 07"
N
E
1,141.04' PROPERTY LINE
74° 41' 48"N
E
440.49' PROPERTY LINE
0° 44' 37"S
E
1,052 .94' PROPERTY L INE
FUTURE GREENHOUSE FUTURE GREENHOUSE FUTURE INDUSTRIAL BUILDINGEXTRACTION
FUTURE GREENHOUSE
FUTURE BUILDING ADDITIONTISSUE CULTURE
FUTURE TRUCK APRON FUTURE TRUCK APRON
FUTURE INTERNAL ROADWAY
FUTURE TRUCK APRONFUTURE TRUCK APRON FUTURE TRUCK APRON
Registered Professional Seal
Owner
Original Scale
Plot Date
Original Sheet Size
GF Project Number
Arch D 24 x 36
THESE DRAWINGS AND DESIGNS ARE EXCLUSIVE PROPERTY OF GARY FIELDS ARCHITECTURE INTERIOR DESIGN PLANNING INC. DO NOT USE, REPRODUCE, TRANSMIT OR TRANSFER THE DRAWINGS AND DESIGNS WITHOUT EXPRESS WRITTEN PERMISSION OF GARY FIELDS ARCHITECTURE INTERIOR DESIGN PLANNING INC.
COPYRIGHT NOTICE
DOCUMENTSTHIS DRAWING FORMS PART OF THE CONTRACT DOCUMENTS AND CONSTRUCTION DOCUMENTS. READ, INTERPRET AND COORDINATE THIS DRAWING WITH ALL OTHER CONTRACT DOCUMENTS AND CONSTRUCTION DOCUMENTS INCLUDING BUT NOT LIMITED TO DRAWINGS, DETAILS, SCHEDULES, LEGENDS, SPECIFICATIONS AND THE DESIGN OF OTHER REGISTERED PROFESSIONALS AND DESIGN CONSULTANTS.
APPLICABLE BUILDING CODE
PROJECT NORTH
P:\1811 34842 Bell Road Deroche BC\A Design\04 Drawings\01 Current\1811 Drawings BUILDING & ATTACHED SITE(Recovery).rvt
5/28/2018 11:48:11 AM
1 : 720
5/28/2018 11:48:11 AM
SITE PLAN
A1.4
PHARMAGREEN BIOTECH CENTRE
38482 BELL ROAD, DEROCHE, BC
WFS PHARMAGREEN INC
ISSUED FOR:DESIGN
1811
THE DESIGN AND THE WORK OF THIS PROJECT SHALL COMPLY WITH BRITISH COLUMBIABUILDING CODE 2012.
A1.4
SITE PLANScale: 1 : 7201
(00) INDEX - ARCHITECTURAL DRAWING SHEETS (HC LIC.)
SHEETNo. SHEET NAME
ISSUED FORPURPOSE:
A-1. DETAIL SITE PLAN HC LICENCE APPLSA-2 FLOOR PLAN HC LICENCE APPLSA-3 FLOOR PLAN - SECURITY HC LICENCE APPLSA-4 DETAIL PLAN - DL SECURE STORAGE HC LICENCE APPLSA-5 DETAIL PLAN - LP SECURE STORAGE HC LICENCE APPLSA-7 BUILDING OUTLINE FOR CCI HC LICENCE APPLS
A-0100. SITE PLAN HC LICENCE APPLSTOTAL SHEETS: 7
REVISION SCHEDULE
REV. DATE ISSUED FOR
Greenhouses:
• To grow and flower the “CBD Dana” strain for the CBD cannabinoids
• To grow and flower various THC strains for the THC cannabinoids and Terpenes content
• To grow bigger various cannabis plants for cultivators wishing to buy bigger plants instead of small plantlets
• To grow cannabis plants for ongoing research and development
Extraction and Distillation Lab:Construction of a separate building for extraction slated for summer of 2019, after occupancy of the Biotech Complex
• Approximate 20,000 square feet• Able to process, extract and distillate 100,000 KG of
raw flower material• For the wholesale of cannabis oils (CBD, THC,
Terpenes)• To provide cannabis extract formulations for
wholesale and Pharmagreen branded cannabis products
Production Facility
Completed design of a semi-automated 58,000 sq ft facility all finished floor space.
y Semi-automated functions for upscale production y Projected cost $ 15 Million y Projected annual plantlet production 10 Million y Sell price $5 per for $50 Million in gross revenues y Cost per plantlet under $1 Dollar y Projected annual profit $40 Million y Upgraded design can be expanded from the main building in all direction.
Pharmagreen’s new subsidiary, BC New Co, will build and operate the cannabis biotech complex. Alliance Growers has entered into a binding Letter of Intent with WFS Pharmagreen Inc. to acquire an equity stake in Pharmagreen’s subsidiary BC New Co.
The purpose of these facilities is to supply licenced cannabis growers with high quality ready-to-grow starter crops in the form of planet culturing. These plantlets are produced using our own proprietary in-vitro “Chibafreen Process.”
The facility will also house a cold storage area utilizing a proprietary Cryotissue Cold Storage technology for long-term preservation of plant tissue samples.
Licenced Medical Marijuana Producers
Alliance Growers is investing in and building strategic partnerships with licensed cannabis producers
at various stages in the licensing process.
BiocannatechAlliance Growers has entered into an exclusive agreement to acquire Biocannatech which is to become a licensed producer under Health Canada’s access to cannabis for medical purposes regulations (“ACMPR”) in Québec.
y incorporated in Québec and located in Côte Saint-Luc, Québec y in the final expedited phase of the ACMPR approval for the production and sales of Medical Marijuana
y has application to Health Canada for building a 10,000 sq. ft. facility with an attached 120,000-sq. ft. warehouse. Projected Gross Revenue is 10 Million per year
y With additional approval the facility can be expanded to 70,000 square feet with a projected Gross Revenue of 70 Million per year
y the operations construction phase is targeted for March 2018 y facility expansion up to 70,000 square feet estimated to be operational in late 2019
CanweAlliance Growers has acquired a 5% equity investment in the Ontario-based cannabis company Canwe.
y has a team of growers and regulatory experts from a profitable previous venture
y has access to a property near Toronto up to 22 acres in size
y plans to build a facility focused on producing clean, premium-quality cannabis
These partnerships secure long-term plantlet sales for the Botany Centre, wholesale cost for flower to be acquired for CBD oil extraction, and ongoing support for the producers.
CBD Oil Production and Distribution
Medical grade CBD has become a highly sought-after compound in the treatment of a range of medical issues.
CBD Oil ProductionAlliance Growers is finalizing terms on a 20% equity investment in an Israeli medical cannabis company.
y ACG will have off-take rights to buy 20% of oil production at or near cost for global distribution
y high-tech extraction allows for production of the highest quality pharmaceutical-grade CBD oil.
y legal 50-hectare grow operation in an offshore, low operating cost jurisdiction
y has secured first government permit to grow cannabis with 4-year exclusivity
y continuing clinical research on medical cannabis
IsraelIsrael’s government has encouraged cannabis research since the 1960's. In 2017 the government announced it is investing $2.13 million in research projects.
The Health Ministry’s Medical Cannabis Unit believes cannabis should be considered in the same manner as any other medicinal product. Licensed suppliers provide cannabis to Israel’s roughly 26,000 registered patients, creating a domestic market of about $15 million to $20 million.
Hebrew University researchers synthesized 22 versions of the cannabinoid THC that have great potential for treating neurological and inflammatory diseases.
After some success in using substance to treat epileptics, Israeli researchers will launch clinical trials to check the effect of cannabis oils on individuals with severe behavioral problems such as autism.
International companies regularly join forces with Israeli academic and medical institutions to create new medications. In February of 2017,a government committee approved a plan that would allow medical marijuana companies to export products internationally.
Spyder is an established vaporizer and eCigarette retailer based in Ontario, with strong revenues and an aggressive growth plan.
The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Revenues for the initial two stores totaled $733,000 for the year ending January 31, 2018. The third store opened in December 2017.
y Now opening locations across Canada y High-end retail service at competitive prices y Top quality cannabis products
Spyder Vapes, as the retail arm for Alliance Growers, will create a true seed-to-sale business for the company and its customers after national legalization.
Research and Technology
Developing technologies that will improve upon the quantity, consistency and distribution of cannabis production giving us a competitive edge in
this ever expanding industry.
CBD DANA HEMP STRAINNamed “CBD DANA,” this stain is unique in its CBD to THC content ratio. The strain has been tested for a content of at least 10% CBD with no more than 0.3% THC. This CBD yield is substantially greater than traditional hemp strains which typically have at most a 1% content. The lower THC content allows the strain to be classified as “industrial hemp” which makes it ideal for cultivation with less restrictive regulation.
As the Cannabinoids are primarily produced in the flower portion of the female plant, eliminating male plants from the crop can allow an additional 80% increased yield in the unpollinated flowers. Selecting for only female plantlets is the best way to ensure this compared to traditional planting from seeds.
The female plantlets produced in the Tissue Culture Lab at the Cannabis Biotech Complex will be available for hemp farmers on a global scale. Providing hemp farmers with all female, fully rooted plantlets of the strain will provide a significant yield in CBD production for hemp farmers.
The commercial production of hemp starts with planting 200,000 female-only tissue cultured plantlets of the proprietary CBD Dana strain in 5 acres of glass greenhouses. Stage two involves moving the plants to a contracted hemp farmer with a secure, 20-acre open field. The plants will yield approximately 100,000 kilograms of CBD flower which in turn will yield 3,000 kilograms of 99% pure CBD Crystals. At approximately $20,000 per kilo this yields a $60 million gross revenue with costs ranging from $20 million to $30 million depending on the lease and contract farming arrangement and the cost of extraction.
Botanical Research In Motion International (B.R.I.M.)B.R.I.M. develops and currently holds rights to new technologies for controlled and precise production of cannabis plants, such as the ‘Chibafreen Process’. WFS Pharmagreen will be utilizing these licenced technologies for the production of plantlets at the Mission Botany Centre. The Botany Centre will also allow B.R.I.M. to do continued research on behalf of WFS Pharmagreen. Tissue-culture cultivation has the potential to become the new standard for the cannabis industry. The consistency of product lends well to future government regulation of molecular composition and potency. There is also further potential to apply these same technologies into other agricultural industries.
Peter Wojcik CEO of B.R.I.M. and WFS Pharmagreen
BA Economics
y CEO and founder of Botanical Research In Motion Inc. (B.R.I.M.)
y graduate from University of Regina with a Bachelor of Arts Advanced, Economics
y successful entrepreneur with past endeavors including a computer hardware company, an Internet service provider and a software company specializing in on-line gambling
y negotiated contracts with high levels of government
y 8 years of experience in cannabis cultivation, production and its application in the treatment of disease
y involved with the design and construction of large facilities and plant growing systems
y acted as a consultant for the implementation of systems design, problem solving, yield maximization and space utilization
Dr. Fawzia Afreen B.R.I.M. Chief Scientist
PhD Plant Science
y expert in plant horticulture, plant tissue culture, and plant production in controlled environments
y has a PhD with a focus on plant science from the Department of Applied Biology; University of Hull, UK in 1998
y research associate at the Department of Botany; University of Guelph, Ontario from 2002 to 2004
y research associate, at Chiba University in Japan where she taught graduate (M.Sc) level courses in protected horticulture, plant tissue culture and plant production in controlled environment from 2004 to 2007
y since 2008, has provided consulting services for Hyacinth Planttech, British Columbia
y has acted as B.R.I.M.'s chief scientist since January 2014 and will oversee the tissue culture lab of the first Botany Center
InitiationParent Multiplication Rooting Acclimatization
An ‘explant’ (shoot-tip or bud) is excised from the stock plant under
sterile conditions.
The explant is placed on a growth medium containing an energy
source and hormones.
The explant rapidly grows new tissue.
This process can be repeated several times.
Individual shoots are moved to a new growth medium which allows the roots to harden.
Plantlets are transferred to soil for
conventional growth in a greenhouse.
y Increased growth of plants results in a 30-50% shorter production period.
y Yields a high percentage of salable plants (over 95%).
y Each plantlet will always have the same genetic makeup as its parent tissue stock.
y Plants are produced under a controlled environment free from pests, pathogens and outside weather conditions.
The Chibafreen Process
Alliance Growers Building a diversified global cannabis company that is focused on where the market is going, not where the market is today.
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
Jan 2018
Dec 2017
Nov 2017
Oct 2017
Sep 2017
Aug 2017
Jul 2017
Jun 2017
May 2017
Apr 2017
Mar 2017
Feb 2017
Jan 20170
2000000
4000000
6000000
8000000
Close
Volume
ACG Canadian Securities Exchange
(as of June 12, 2018)
1LA Frankfurt Stock Exchange
(FWB Germany)
64,843,890Shares Issued & Outstanding
73,981,298Shares Fully Diluted
ALGWF Alliance has applied for a listing on the OTCQB Venture Market
ManagementDennis PetkeChartered AccountantCEO and President of Alliance Growers
Harvey LawsonMaster of Business AdministrationCFO of Alliance Growers
DirectorsDennis PetkeChartered Accountant
Rupert ShoreBarrister and Solicitor
Sina PiroozPresident of SP RX ServicesRegistered Pharmacist
Ian LambertBachelor of CommerceCEO, Director of West Nevada Resources Inc.
AdvisorsRob GraceCorporate Development Advisor
Robert CarvethBiotechnology and Gov. Relations Advisor
Charles RendinaRegulatory and Financial Advisor
Edmund ObasiCannabis Investment Advisor
Frontier Merchant Capital GroupInvestor Relations and Consulting Services
Chilco DesignMarketing and Branding
Strategic investments in ACMPR applicants that leads to long
term tissue culture supply contracts.
Private placementopportunity providing the best value in
booming cannabis sector
BiocannaTechQuebec facility expansion up to 70,000
square feet estimated to beoperational in late 2019.
Spyde Vapesas a Canadian cost-to-cost retailer for cannabis products after legalization.W
Cannabis Botany Centreto be developed in Mission BC for
production of plantlets for distribution to licensed producers.
$ 5 million equity facility in a series of private placements via
Alumina Partners (Ontario) Ltd. with an option to extend up to $10 million.
Investment Highlights
Use of Financing Proceeds y Development of the Cannabis Botany Centre in Mission, BC y Acquisition and development of the BiocannaTech facility in Québec y Spyder Vapes expansion across Canada y Furthering of strategic partnerships y Equity investment in WFS Pharmagreen y Equity Investment in CANWE y General working capital
ALLIANCE GROWERS
© 2018 Chilco Design Studio Inc.
ACGCanadian Securities Exchange
1LAFrankfurt Stock Exchange
For investment contact:
Rob GraceCorporate Development
For information contact:
Dennis PetkePresident & CEO778-558-7434